KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Dividends Paid - Common Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Paid (Common) Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 15.01%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 4.75%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 5.50%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 2.68%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 6.18%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 3.59%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 0.33%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 1.99%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 4.75%
Dec 28, 2025 4.93%
Sep 28, 2025 4.92%
Jun 29, 2025 4.82%
Mar 30, 2025 4.18%
Dec 29, 2024 4.15%
Sep 29, 2024 3.97%
Jun 30, 2024 -3.46%
Mar 31, 2024 -2.48%
Dec 31, 2023 -16.74%
Apr 2, 2023 5.56%
Apr 3, 2022 4.81%
Oct 3, 2021 4.96%
Jul 4, 2021 4.96%
Apr 4, 2021 6.15%
Jan 3, 2021 6.32%
Sep 27, 2020 6.40%
Jun 28, 2020 5.43%
Mar 29, 2020 4.55%
Dec 29, 2019 3.69%
Sep 29, 2019 3.48%
Jun 30, 2019 4.43%
Mar 31, 2019 6.35%
Dec 30, 2018 6.87%
Sep 30, 2018 7.14%
Jul 1, 2018 6.76%
Apr 1, 2018 3.78%
Dec 31, 2017 -10.48%
Apr 2, 2017 4.93%
Apr 3, 2016 6.32%
Sep 27, 2015 5.54%
Jun 28, 2015 5.11%
Mar 29, 2015 4.23%
Dec 28, 2014 5.05%
Sep 28, 2014 5.64%
Jun 29, 2014 6.57%
Mar 30, 2014 9.44%
Dec 29, 2013 10.18%
Sep 29, 2013 10.64%
Jun 30, 2013 10.74%
Mar 31, 2013 9.01%
Dec 30, 2012 -7.80%
Apr 1, 2012 5.74%
Apr 3, 2011 9.63%
Oct 3, 2010 9.84%
Jul 4, 2010 10.30%
Apr 4, 2010 6.05%